GoodRx Holdings, Inc. (GDRX), a digital healthcare platform, Thursday reported net income of 6.69 million or $0.02 per share for the second quarter, significantly lower than 58.79 million or $0.14 per share in the same quarter a year ago, mainly due to an income tax benefit of $46.72 million in the previous year.
Excluding one-time items, earnings were $32.37 million or $0.08 per share, up from $28.39 million or $0.07 per share a year ago.
Operating income increased to $19.88 million from $18.31 million last year.
Revenue for the quarter grew to $200.61 million from $189.68 million in the previous year.
On average, 14 analysts polled by Thomson-Reuters expected the company to report earnings of $0.09 per share on revenue of $200.44 million. Analysts estimates typically exclude special items.
For the third quarter, the company expects revenue in the range of $193 million - $197 million. The consensus estimate stands at $202.37 million.
For the full year, GoodRx now expects revenue to be at the low end of its previous outlook of $800 million - $810 million. The Street is looking for revenue of $806.38 million.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.